OptiNose Performance
| OPTNDelisted Stock | USD 9.60 0.07 0.72% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and OptiNose are completely uncorrelated. OptiNose right now holds a risk of 0.0%. Please check OptiNose accumulation distribution and period momentum indicator , to decide if OptiNose will be following its historical price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days OptiNose has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, OptiNose is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
OptiNose |
OptiNose Relative Risk vs. Return Landscape
If you would invest 960.00 in OptiNose on October 23, 2025 and sell it today you would earn a total of 0.00 from holding OptiNose or generate 0.0% return on investment over 90 days. OptiNose is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than OptiNose, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
OptiNose Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for OptiNose's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as OptiNose, and traders can use it to determine the average amount a OptiNose's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| OPTN |
Based on monthly moving average OptiNose is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of OptiNose by adding OptiNose to a well-diversified portfolio.
OptiNose Fundamentals Growth
OptiNose Stock prices reflect investors' perceptions of the future prospects and financial health of OptiNose, and OptiNose fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on OptiNose Stock performance.
| Return On Equity | -10.5 | |||
| Return On Asset | -0.0997 | |||
| Profit Margin | (0.37) % | |||
| Operating Margin | (0.41) % | |||
| Current Valuation | 152.68 M | |||
| Shares Outstanding | 10.13 M | |||
| Price To Earning | (3.41) X | |||
| Price To Book | 24.26 X | |||
| Price To Sales | 1.19 X | |||
| Revenue | 78.23 M | |||
| EBITDA | (1.2 M) | |||
| Cash And Equivalents | 78.26 M | |||
| Cash Per Share | 0.94 X | |||
| Total Debt | 128.96 M | |||
| Book Value Per Share | (6.06) X | |||
| Cash Flow From Operations | (44.89 M) | |||
| Earnings Per Share | (2.17) X | |||
| Total Asset | 128.78 M | |||
| Retained Earnings | (741.92 M) | |||
| Current Asset | 83.03 M | |||
| Current Liabilities | 12.11 M | |||
About OptiNose Performance
By examining OptiNose's fundamental ratios, stakeholders can obtain critical insights into OptiNose's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that OptiNose is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. Optinose operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 189 people.Things to note about OptiNose performance evaluation
Checking the ongoing alerts about OptiNose for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for OptiNose help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| OptiNose is not yet fully synchronised with the market data | |
| OptiNose has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 78.23 M. Net Loss for the year was (21.54 M) with profit before overhead, payroll, taxes, and interest of 74.11 M. | |
| OptiNose currently holds about 78.26 M in cash with (44.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.94. | |
| Roughly 72.0% of the company shares are owned by institutional investors |
- Analyzing OptiNose's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether OptiNose's stock is overvalued or undervalued compared to its peers.
- Examining OptiNose's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating OptiNose's management team can have a significant impact on its success or failure. Reviewing the track record and experience of OptiNose's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of OptiNose's stock. These opinions can provide insight into OptiNose's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in OptiNose Stock
If you are still planning to invest in OptiNose check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OptiNose's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |